CBD and Longevity Protocols: NAD+, Senolytics, and the Anti-Aging Stack | PureCraft CBD

Medical Disclaimer| This article is for informational purposes only. Rapamycin and dasatinib are prescription medications requiring physician management — do not use them without a prescriber, and inform your physician about CBD before combining. CBD and OTC longevity supplements are supplements, not medications. Longevity medicine is an evolving field — consult a physician knowledgeable in this area for personalized guidance. PureCraft CBD products are broad-spectrum zero-THC, batch-verified at purecraftcbd.com/pages/faq. Individual results may vary.

The Longevity Biology Revolution and CBD's Position

Longevity medicine — the deliberate pharmacological and supplemental modulation of aging biology to extend healthspan — has moved from science fiction to active clinical research in the past decade. The key biological aging pathways are now well-characterized: NAD+ decline (driving mitochondrial dysfunction and epigenetic aging), senescent cell accumulation (producing the SASP inflammatory burden that drives tissue dysfunction), mTOR hyperactivation (imparing cellular recycling), telomere shortening (limiting cell division capacity), and neuroinflammation (the primary driver of cognitive aging). Each pathway has emerging pharmacological and supplemental interventions, and the question for CBD is: where does it fit?

CBD's longevity relevance is neither the most central mechanism (NMN/NR for NAD+ is more directly targeted) nor peripheral (anti-neuroinflammation is a top-three longevity target). CBD addressestwo high-priority longevity pathways: neuroinflammation (CB2 microglial — arguably the most important longevity target for brain healthspan) and the HPA-cortisol-telomere axis (chronic cortisol accelerates telomere shortening, the cellular aging clock). These are genuine longevity mechanisms, not general wellness claims reframed as anti-aging. This guide is the final post of the biohacking cluster — seeThe Complete CBD Biohacker's Protocol: Stacking CBD With Every Major Wellness Practice for the integrated framework andCBD and Healthy Aging: The Complete 2027 Guide for the complete healthy aging guide.

The Five Major Longevity Pathways and CBD's Roles

Pathway 1: NAD+ Decline — NMN/NR + CBD

NAD+ (nicotinamide adenine dinucleotide) declines approximately 50% between age 40 and 60 in most tissues — producing reduced mitochondrial efficiency, impaired DNA repair (NAD+ is the substrate for PARP-mediated DNA repair), reduced SIRT1/SIRT3 sirtuin deacetylase activity (epigenetic aging regulators), and accumulating cellular damage that underlies the aging phenotype. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the most studied NAD+ precursors — multiple human trials have confirmed they raise NAD+ levels effectively in blood and muscle.

CBD's relationship to the NAD+ pathway is indirect but mechanistically coherent: CB2's anti-neuroinflammatory mechanism reduces the chronic inflammatory burden that accelerates NAD+ depletion (inflammatory activation consumes NAD+ via CD38 enzyme upregulation — reducing inflammation reduces this NAD+ drain). CBD's HPA recalibration reduces cortisol-driven oxidative stress that further depletes NAD+. The combination of NMN 500mg +CBD Oil 15mg AM provides both direct NAD+ precursor supplementation and the anti-inflammatory protection that slows NAD+ depletion — addressing both the production and conservation dimensions of NAD+ homeostasis.

Pathway 2: Senescent Cells — Senolytics + CBD

Senescent cells — cells that have permanently exited the cell cycle but resist apoptosis — accumulate with aging in tissues throughout the body. Their clinical significance: they secrete a pro-inflammatory cocktail called the SASP (senescence-associated secretory phenotype) containing IL-6, IL-1β, TNF-α, MMPs, and growth factors that damage neighboring tissue, promote chronic inflammation, impair stem cell function, and create the tissue dysfunction that characterizes aging. Clearing senescent cells with senolytics produces dramatic rejuvenation in animal models.

Quercetin + dasatinib is the most studied senolytic combination (Zhu et al., 2015; Mayo Clinic Phase II human trials). Quercetin (OTC) selectively kills senescent cells through BCL-2/BCL-XL inhibition; dasatinib (Rx, leukemia drug) adds complementary senolytic activity. Neither is a chronic daily supplement — senolytics are typically used intermittently (days on, weeks or months off) in clinical longevity protocols.

CBD's SASP-relevant mechanism: CB2 macrophage M1→M2 recalibration reduces theinflammatory output of the SASP — the cytokines that senescent cells secrete. CBD doesn't clear senescent cells (that's quercetin's job) but it manages the inflammatory damage they produce between senolytic cycles. The combination: quercetin intermittent dosing (clearing cells) + dailyCBD Oil (managing their inflammatory output) provides both senolytic clearance and SASP inflammatory management.Dasatinib requires physician prescription and has no CYP450 interaction with CBD — but using any Rx senolytic requires longevity physician management.

Pathway 3: mTOR and Autophagy — Spermidine and Rapamycin

mTOR (mechanistic target of rapamycin) is a master growth-promoting kinase that, when chronically overactive with age and nutrient excess, suppresses autophagy — the cellular recycling system that clears damaged proteins, organelles, and mitochondria. Rapamycin (the most potent known mTOR inhibitor) produces life extension in every mammalian model tested and is the most pharmacologically powerful longevity drug available. Spermidine (a polyamine found in foods and now available as a supplement) activates autophagy via independent mechanisms from rapamycin.

The rapamycin-CBD interaction is the most important drug interaction in this post. Rapamycin is a CYP3A4 substrate with a very narrow therapeutic window — the difference between therapeutic and toxic levels is small. CBD's CYP3A4 inhibition could meaningfully increase rapamycin plasma levels, potentially producing rapamycin toxicity (immune suppression, wound healing impairment, metabolic effects).Do not combine CBD with rapamycin without physician management and rapamycin level monitoring. This is not a reason to avoid CBD if not using rapamycin — it is a critical safety note for the subset of longevity enthusiasts who are using physician-supervised rapamycin. SeeCBD and Drug Interactions: The Complete CYP450 Guide. 

Spermidine (1mg daily from wheat germ extract) has no CYP450 interaction with CBD and provides the autophagy activation that CBD's mechanisms do not directly produce — a complementary mechanism. The combination of spermidine (clears damaged mitochondria via mitophagy) + CBD CB2 (protects healthy mitochondria from inflammatory damage) provides complementary mitochondrial quality control from two different directions.

Pathway 4: Telomere Biology — CBD's HPA-Cortisol-Telomere Role

Telomeres — the protective caps on chromosomes — shorten with each cell division and with oxidative stress, representing one of the biological clocks of cellular aging. Chronic psychological stress and elevated cortisol accelerate telomere shortening through oxidative stress and telomerase (the telomere-extending enzyme) suppression. This is one of the most documented molecular mechanisms linking chronic stress to accelerated biological aging.

CBD Oil's HPA recalibration — reducing the chronic cortisol elevation that accelerates telomere shortening — represents a genuine longevity mechanism through the stress-telomere axis. This is more specific than a general 'stress reduction' anti-aging claim: the molecular link between cortisol → oxidative stress → telomerase inhibition → telomere shortening is well-characterized, and CBD's HPA mechanism is directly positioned in that pathway. CBD is not a telomerase activator, but reducing the cortisol-driven telomere attrition rate has the same directional effect on biological age as the stress-management literature predicts.

Pathway 5: Neuroinflammation — CBD's Central Longevity Contribution

Neuroinflammation — chronic microglial M1 activation in the brain — is arguably the most important longevity target for cognitive healthspan, which is what most people care most about when they consider 'healthy aging.' The progressive accumulation of neuroinflammation with age drives the cognitive decline that is the most feared aspect of aging: Alzheimer's, other dementias, and the subclinical cognitive erosion that precedes clinical diagnosis.

CBD Oil's CB2 microglial M1→M2 recalibration is one of the most directly targeted OTC anti-neuroinflammatory mechanisms available. Daily CBD is, in this framework, not just an anxiety supplement — it is a neuroinflammation management intervention with longevity implications for the cognitive healthspan that depends on containing the microglial activation that compounds with each decade. SeeCBD and Cognitive Decline: What the Research Shows for Brain Aging.

The Complete Anti-Aging Supplement Reference Table

The longevity table's most important safety rows are rapamycin (narrow therapeutic window + CYP3A4 = significant interaction) and dasatinib (Rx senolytic — physician required). Every other compound in the table can be combined withCBD Oil at standard supplement doses without significant pharmacokinetic concern. The interaction column is deliberately specific — the goal is not to discourage stacking but to identify the precise interactions that require medical supervision.

The Complete Longevity Stack Protocol

The evidence-based CBD longevity stack, organized by priority and evidence level:

Total morning longevity stack:CBD Oil 15mg + CoQ10 200mg + NMN 500mg + Resveratrol 250mg (with fat) + Spermidine 1mg = the 5-compound CBD longevity core. Add quercetin senolytic cycles as directed by a longevity physician.

Evidence Honesty: What the Longevity Research Actually Shows

The longevity supplement space has a significant hype problem — the gap between preclinical animal model data and human clinical confirmation is enormous, and the incentive to market supplements with dramatic longevity claims exceeds the current evidence in almost every category.

Honest evidence assessment for the CBD longevity stack:

Frequently Asked Questions

How does CBD fit into a longevity stack?

CBD Oil contributes to longevity through: (1) CB2 anti-neuroinflammation — managing the microglial activation that drives cognitive aging; (2) FAAH/anandamide/BDNF neuroprotection — maintaining neuroplasticity; (3) HPA-cortisol-telomere preservation — reducing the stress-accelerated biological aging rate; (4) CB2 anti-inflammaging — reducing the systemic chronic inflammation that predicts aging trajectory. These are mechanistically specific contributions to well-characterized longevity pathways, not generic 'anti-aging' claims.

CBD and NMN — is this a good stack?

Yes —CBD Oil + NMN 500mg AM is a well-reasoned longevity combination. CBD's CB2 mechanism reduces the CD38-mediated NAD+ drain from chronic inflammation, while NMN directly restores NAD+ via the biosynthesis pathway. They address the same NAD+ homeostasis goal from production (NMN) and conservation (CBD anti-inflammatory) directions. No pharmacokinetic interaction. Add CoQ10 200mg to complete the mitochondrial tier: NMN restores NAD+ for SIRT3, CoQ10 restores electron transport chain function, CBD protects the mitochondrial membrane — three layers of mitochondrial support.

Can CBD and rapamycin be combined?

Only under physician management. Rapamycin is a CYP3A4 substrate with a narrow therapeutic window — CBD's CYP3A4 inhibition may increase rapamycin plasma levels and produce toxicity. If your longevity physician has prescribed rapamycin: disclose CBD use before starting or continuing. The physician may reduce the rapamycin dose or recommend discontinuing CBD during rapamycin cycles.Never combine these without prescriber knowledge and monitoring. SeeCBD and Drug Interactions: The Complete CYP450 Guide.

What are senolytics and how does CBD complement them?

Senolytics are compounds that selectively clear senescent ('zombie') cells — cells that have permanently stopped dividing but resist dying, secreting the SASP (pro-inflammatory cytokines, proteases, growth factors) that damages surrounding tissue. Quercetin + dasatinib is the most studied senolytic combination. CBD's role: CB2 macrophage recalibration manages the inflammatory SASP output between senolytic cycles — reducing the damage that senescent cells produce while they accumulate before the next clearing cycle. CBD (daily) + quercetin (intermittent monthly/quarterly cycles) is the OTC component of a senolytic protocol; dasatinib requires physician prescription.

Does CBD slow aging?

No human trial has demonstrated that CBD slows aging as measured by biological age clocks (epigenetic methylation, telomere length, etc.). The mechanistic case is well-founded — neuroinflammation management, HPA-cortisol-telomere protection, and FAAH/BDNF neuroprotection all target well-characterized aging mechanisms. But 'mechanistically targeted' is not 'clinically proven to slow aging.' CBD's most defensible longevity claim is as a daily anti-neuroinflammatory and stress-cortisol management intervention that, combined with the broader longevity stack, addresses aging biology comprehensively. SeeCBD and Healthy Aging: The Complete 2027 Guide.

What is the best anti-aging supplement stack?

CBD Oil 15–20mg AM (neuroinflammation, HPA, ECS) + NMN 500mg (NAD+ restoration) + CoQ10 ubiquinol 200mg (mitochondrial ATP) + Trans-Resveratrol 250mg with fat (SIRT1, Nrf2) + Spermidine 1mg (autophagy) + Quercetin 1g intermittently (senolytic) +CBD+CBN Sleep Gummies nightly (glymphatic waste clearance during sleep + GH pulsatility for repair). This represents the most comprehensive OTC anti-aging supplement protocol available in 2027 — covering NAD+, mitochondria, senolytics, autophagy, neuroinflammation, and sleep rejuvenation through mechanistically independent interventions.

The Bottom Line: CBD in the Longevity Stack

CBD occupies a specific and genuinely valuable position in the longevity supplement landscape — not as the centerpiece (NMN and CoQ10 have more directly targeted age-reversal mechanisms) but as the anti-neuroinflammatory foundation that manages the inflammatory aging process that the other interventions are working to overcome. The chronic neuroinflammation, HPA-cortisol telomere attrition, and SASP inflammatory burden that CBD daily use addresses are the underlying biology that every other longevity intervention is fighting against.

The practical framework: CBD as the anti-inflammaging daily foundation + NMN for NAD+ + CoQ10 for mitochondria + resveratrol for SIRT1 + quercetin (intermittent) for senolytics + Sleep Gummies for the glymphatic clearance that occurs during sleep. Physician consultation for any prescription longevity compounds (rapamycin, dasatinib, metformin).

PureCraft CBD Oil 1000mg — 15–20mg AM.CBD+CBN Sleep Gummies — nightly. Zero THC, nano-optimized,batch-tested COA.browse all PureCraft CBD products.

Medical Disclaimer| Longevity medicine is an evolving field. Rapamycin and dasatinib are prescription medications requiring physician management — do not combine with CBD without prescriber oversight. OTC longevity supplements are supplements, not medications. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Related Articles — Longevity, Aging & Biohacking

•CBD and Healthy Aging: The Complete 2027 Guide

•CBD and Cognitive Decline: What the Research Shows for Brain Aging

•The Complete CBD Biohacker's Protocol: Stacking CBD With Every Major Wellness Practice

•CBD and Nootropic Stacking: Cognitive Enhancement Beyond Lion's Mane

•CBD vs Resveratrol: Antioxidant, Anti-Aging, and Cardiovascular Comparison

•CBD vs CoQ10: Energy, Mitochondria, and Cardiovascular Health

•CBD for Inflammation: What the Science Actually Says

•CBD for Sleep: The Ultimate 2026 Guide to Better Rest

•CBD and Drug Interactions: The Complete CYP450 Guide

•How the Endocannabinoid System Regulates Your Body: A Deep Dive

Sources & Citations

•Zhu et al. (2015): The Achilles' heel of senescent cells — from transcriptome to senolytic drugs — Aging Cell — quercetin + dasatinib senolytics → PubMed 25754370

•Yoshino et al. (2021): Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women — Science — NMN human trial → PubMed 34857650

•Pietrocola et al. (2019): Spermidine induces autophagy — Cell — spermidine autophagy → PubMed 31564498

•Blackburn & Epel (2012): Too toxic to ignore — Nature — stress, telomeres and aging → PubMed 22895156

•Atalay et al. (2019): Antioxidative and Anti-Inflammatory Properties of CBD — Antioxidants → PubMed 31817459